Create Alert
Watchlist

Aurobindo Pharma

1033.75
0.00 (0.00%) 1D
NSE
1D
1W
1M
1Y
3Y
5Y
All

Performance

Open
1,049.00
Prev. Close
1,033.75
Volume
12,27,116
Total traded value
127 Cr
Upper Circuit
1,137.10
Lower Circuit
930.40

Market Depth

Buy order quantity
Sell order quantity
%
%
Loading...
Bid Total
198
Loading...
Ask Total
0

Analyst Estimates

56%
Buy
56%
Hold
28%
Sell
16%
Aggregated by Refinitiv from 25 Analysts

Fundamentals

Market Cap₹60,563Cr
ROE8.25%
P/E Ratio(TTM)26.04
EPS(TTM)39.69
P/B Ratio2.15
Dividend Yield0.73%
Industry P/E32.29
Book Value481.09
Debt to Equity0.24
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Aurobindo Pharma

Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals and related services. Its product portfolio is spread over seven therapeutic/product areas encompassing Central nervous systems (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Orals & Sterile, Anti-infectives, Anti-diabetics and Cephalosporins - Orals. It is engaged in developing a range of oncology and hormonal products. It is developing topical as well as transdermal products in the dermatology therapeutic segment. It is also developing about three depot injections based on the microsphere and nano-suspension technology platforms. The Company is marketing its products globally in approximately 150 countries. The Company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited, and others.;
Parent OrganisationAurobindo Pharma Limited
Founded1986
Managing DirectorMr. K. Nityananda Reddy
NSE SymbolAUROPHARMA

Shareholding Pattern

Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Promoters
51.83%
Foreign Institutions
22.45%
Mutual Funds
11.27%
Retail And Others
7.78%
Other Domestic Institutions
6.67%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
₹1,231.25
(+0.44%)
34.56
Cipla
₹1,205.70
(-0.54%)
28.21
Dr Reddy's Laboratories
₹5,749.40
(-0.67%)
18.83
Mankind Pharma
NA
(0.00%)
49.31
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW